Judith is a multiple award-winning pharmacist and molecular biotechnologist with a strong interest in oncology. She is currently undertaking her doctoral studies in Cancer Biology at the Washington University in St. Louis. Her passion for science cuts across basic science research and improving access to quality healthcare for patients with low socio-economic backgrounds. She is passionate about developing new, improved, and individualized cancer therapeutics and ensuring that these cutting-edge discoveries are made accessible to all, especially the under-served communities. Asides from her interests in healthcare and clinical research, Judith is also involved in mentorship and career advisory for college undergraduates and young graduates. She is a proud Nigerian and loves to sing and travel.
Scholar Voices Feature
American Society of Hematology Selects Judith Sokei to Receive the 2024 ASH Graduate Hematology Award
Judith Sokei has been selected by the American Society of Hematology (ASH) to participate as one of nine graduate students in the 2024 ASH Graduate Hematology Award (AHGA). This award aims to encourage graduate students in the United States and Canada to pursue a career in academic hematology.
From July 1, 2024, to June 30, 2026, AGHA participants will conduct hematology research in one of the following categories: basic, translational, outcomes-based, or patient-oriented clinical research. They will each receive an annual $40,000 stipend for a two-year period to fund their research. Each AGHA participant also receives ASH membership throughout graduate school.
Judith, a Global Scholar from Nigeria, is currently pursuing a PhD in Cancer Biology at WashU School of Medicine.
My mission for a cancer-free future
McDonnell Scholar Judith Sokei’s career and research featured in Vanguard News
By Ayo Onikoyi
In the field of transformative cancer therapeutics, Judith Sokei stands out as a pioneer committed to completely changing the field through her unwavering search for revolutionary cancer treatments.
A beacon of hope and inspiration for many, she converts scientific genius into tangible advances that carry the promise of a brighter future for cancer patients around the world.
As a cancer researcher with extensive knowledge of nanotechnology, she uses it to tailor drug delivery and improve therapy effectiveness. Her journey, distinguished by resilience, commitment, and innovative discoveries, serves as a model for those who want to push the boundaries of medical science and the goal of a cancer-free future.